A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles

A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles

Dimethyl fumarate is a cytoprotective and immunomodulatory drug used in the treatment of multiple sclerosis. We performed a bibliometric study examining the characteristics and trends of the top 100 cited articles that include dimethyl fumarate in the title. On 21 September 2020 we carried out an el...

Full description

Bibliographic Details
Main Authors:	Francisco Javier García-Fernández, Alba Estela García-Fernández, Ichiro Ikuta, Eduardo Nava, Julian Solis García del Pozo, Joaquin Jordan, Maria F. Galindo
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Molecules
Subjects:	dimethyl fumarate Tecfidera multiple sclerosis bibliometric study
Online Access:	https://www.mdpi.com/1420-3049/26/4/1085

Similar Items

Fingolimod Augments Monomethylfumarate Killing of GBM Cells
by: Paul Dent, et al.
Published: (2020-01-01)

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells
by: Paul Dent, et al.
Published: (2020-04-01)

Patients monitoring during treatment with Dimethyl fumarate (ORP-23)
by: Ali Yousefi Pour
Published: (2023-01-01)

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
by: Martina Burlando, et al.
Published: (2021-10-01)

Effects of dimethyl fumarate on neuroprotection and immunomodulation
by: Albrecht Philipp, et al.
Published: (2012-07-01)

The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary Results
by: Thilo Gambichler, et al.
Published: (2023-01-01)

Dimethyl fumarate reduces inflammation in chronic active multiple sclerosis lesions
by: Zinger, Nicole, et al.
Published: (2023)

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
by: Laura Gnesotto, et al.
Published: (2023-03-01)

Dimethyl fumarate for treating Papillon–Lefèvre syndrome
by: Abdullah Al-Omair, MD, et al.
Published: (2023-01-01)

Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023-07-01)

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
by: Stephanie Kourakis, et al.
Published: (2020-10-01)

Utilization of dimethyl fumarate and related molecules for treatment of multiple sclerosis, cancer, and other diseases
by: Azzam Maghazachi, et al.
Published: (2016-07-01)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021-05-01)

Effect and mechanism of dimethyl fumarate on septic cardiomyopathy in mice
by: MIN Weixiang, et al.
Published: (2022-11-01)

The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
by: Federico Manai, et al.
Published: (2022-12-01)

Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
by: Cara A. Timpani, et al.
Published: (2020-12-01)

Repurposing dimethyl fumarate for gastric ulcer and ulcerative colitis: Evidence of local efficacy without systemic side effect
by: Vishal Patel, et al.
Published: (2022-12-01)

The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
by: Roberto De Masi, et al.
Published: (2021-01-01)

Dimethyl Fumarate Used as an Effective Treatment for Granuloma Annulare Disseminatum: An Immunohistochemical Case Study
by: Max Gabutti, et al.
Published: (2023-08-01)

Genetic Study of Severe Prolonged Lymphopenia in Multiple Sclerosis Patients Treated With Dimethyl Fumarate
by: Dipen Sangurdekar, et al.
Published: (2019-11-01)

Comparison of dimethyl fumarate and interferon outcomes in an MS cohort
by: Neda Sattarnezhad, et al.
Published: (2022-07-01)

USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS
by: V. R. Mkrtchyan, et al.
Published: (2016-12-01)

Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise
by: Shilu Deepa Thomas, et al.
Published: (2022-04-01)

Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEM
by: Angel Chinea, et al.
Published: (2020-05-01)

Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge
by: Hallel C. Paraiso, et al.
Published: (2018-03-01)

Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM
by: Mitzi J. Williams, et al.
Published: (2020-05-01)

Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients
by: Alicia Sánchez-Sanz, et al.
Published: (2023-07-01)

Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
by: Maria Rosito, et al.
Published: (2020-08-01)

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
by: Rosés Gibert P, et al.
Published: (2022-06-01)

Gliosis attenuation in experimental autoimmune encephalomyelitis by a combination of dimethyl fumarate and pregabalin
by: Amanda Garcia Hoelz, et al.
Published: (2022-08-01)

Dimethyl fumarate ameliorates endotoxin-induced acute kidney injury against macrophage oxidative stress
by: Kejun Zhou, et al.
Published: (2021-01-01)

Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
by: Kaiyuan Chen, et al.
Published: (2021-02-01)

Dimethyl Fumarate as Potential Treatment for Alzheimer’s Disease: Rationale and Clinical Trial Design
by: Robert Sharkus, et al.
Published: (2023-05-01)

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
by: Xiaoliang Hu, et al.
Published: (2022-04-01)

Dimethyl fumarate prevents acute lung injury related cognitive impairment potentially via reducing inflammation
by: Xiaowei Wang, et al.
Published: (2021-11-01)

Drug repurposing: Clemastine fumarate and neurodegeneration
by: Jiahui Zhu, et al.
Published: (2023-01-01)

Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease
by: Ting Wang, et al.
Published: (2024-02-01)

The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical Utility
by: Lorena Lorefice, et al.
Published: (2021-09-01)

New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
by: Paolinelli Matteo, et al.
Published: (2022-12-01)

Dimethyl Fumarate Triggers the Antioxidant Defense System in Human Retinal Endothelial Cells through Nrf2 Activation
by: Federico Manai, et al.
Published: (2022-09-01)